| 2015 |
SPIN1 directly enhances expression of GDNF (an activator of the RET signaling pathway) in cooperation with the transcription factor MAZ by binding to chromatin; a reader-domain mutation that interferes with chromatin binding reduces liposarcoma cell proliferation and survival, demonstrating that chromatin association is required for SPIN1's oncogenic function. |
Genome-wide chromatin binding (ChIP-seq), transcriptome analysis, knockdown of SPIN1/MAZ, active-site mutagenesis of the reader domain, xenograft mouse models |
Oncotarget |
High |
25749382
|
| 2018 |
SPIN1 sequesters the ribosomal protein uL18 (RPL5) in the nucleolus, preventing uL18 from interacting with MDM2 and thereby relieving uL18-mediated inhibition of MDM2 ubiquitin ligase activity toward p53. SPIN1 depletion increases free uL18 and uL5, which are required for SPIN1-depletion-induced p53 activation. |
Co-immunoprecipitation (SPIN1–uL18 binding), nucleolar fractionation, knockdown/ablation of SPIN1, epistasis with uL18/uL5 depletion, cell growth/apoptosis assays |
eLife |
High |
29547122
|
| 2019 |
SPIN1 is a methyllysine reader protein; a potent and selective fragment-like inhibitor (MS31/compound 3) was developed that binds specifically to tudor domain II of SPIN1, blocking binding of trimethyllysine-containing peptides. Crystal structure of the SPIN1–MS31 complex confirmed tudor domain II selectivity. |
Biochemical binding assay (trimethyllysine peptide displacement), crystal structure determination (SPIN1–inhibitor complex), cellular target engagement assay |
Journal of medicinal chemistry |
High |
31260300
|
| 2024 |
SPIN1 co-crystal structure with compound 11 confirmed that inhibitors occupy one of the three Tudor domains of SPIN1. A SPIN1-selective inhibitor (MS8535/compound 18) disrupts SPIN1–H3 interactions in cells in a concentration-dependent manner and shows oral bioavailability in mice. |
Co-crystal structure (SPIN1–compound 11), selectivity panel (38 epigenetic targets), cellular NanoBRET/proximity assay, pharmacokinetic assessment in mice |
Journal of medicinal chemistry |
High |
38533580
|
| 2024 |
CH3–π interactions between methyl groups of asymmetric dimethylarginine (H3R8me2a) and aromatic cage residues in the SPIN1 triple Tudor domain are electrostatically tunable (cation-π character), providing a mechanistic explanation for how arginine methylation creates a new binding epitope recognized by SPIN1. |
Quantitative binding assays with Tudor domain mutants, computational electrostatic analysis (cation-π), model peptide experiments (NMR/fluorescence) |
Journal of the American Chemical Society |
Medium |
39023428
|
| 2024 |
SPIN1 is recruited to DNA double-strand break lesions via its N-terminal intrinsically disordered region (IDR) that binds Poly-ADP-ribose (PAR). At damage sites, SPIN1 promotes H3K9me3 accumulation and enhances the interaction between H3K9me3 and Tip60, thereby activating ATM and homologous recombination (HR) repair. |
Laser micro-irradiation/live-cell imaging (recruitment assay), PAR binding assay, Co-IP (SPIN1–Tip60–H3K9me3), knockdown with DSB repair readouts (γH2AX, HR reporter), ATM activation assay |
EMBO reports |
High |
39090319
|
| 2024 |
SPIN1's N-terminal IDR drives formation of liquid-like phase-separated condensates that recruit the histone methyltransferase MLL1, enrich H3K4 methylation marks, facilitate SPIN1 binding to H3K4me3, and enhance SPIN1 genome-wide chromatin binding at MAPK pathway genes. |
Phase separation assay in vitro and in cells (fluorescence microscopy, FRAP), Co-condensate assay (SPIN1–MLL1), ChIP-seq (genome-wide chromatin occupancy with and without IDR), H3K4me3 ChIP |
Journal of molecular cell biology |
Medium |
38777743
|
| 2024 |
SPIN1 facilitates MDM2-mediated ubiquitination and degradation of FOXO3a, leading to upregulation of FOXM1, which in turn promotes DNA double-strand break repair and NSCLC radioresistance. |
Knockdown/overexpression with cell proliferation, cell-cycle (G2/M), clonogenic, and DSB-repair assays; rescue experiments with FOXM1 restoration; ubiquitination assay for FOXO3a |
Cell death & disease |
Medium |
39548064
|
| 2024 |
SPIN1 forms a stable complex with WDR76 while recognizing H3K4me3; cross-linking mass spectrometry and integrative structural modeling (Bayesian IMP) built a model of WDR76:SPIN1 bound to the nucleosome. Interaction network analysis of co-purifying proteins implicated this complex in the DNA damage response. |
Serial capture affinity purification (SCAP), cross-linking mass spectrometry, Bayesian Integrative Modeling Platform (IMP), co-purification of H3K4me3, fluorescence microscopy |
Proceedings of the National Academy of Sciences of the United States of America |
High |
39116123
|
| 2025 |
The SCMC component FILIA directly interacts with SPIN1 and retains it in the cytoplasm. Loss of FILIA causes residual SPIN1 to translocate to the nucleus, where it impairs H3K4me3 reprogramming and zygotic genome activation by competing with KDM5B for binding to H3K4me3. |
Co-immunoprecipitation (FILIA–SPIN1), subcellular fractionation/immunofluorescence (cytoplasmic vs. nuclear SPIN1), embryo live imaging, H3K4me3 ChIP in embryos, FILIA knockout mice, H3K4me3–SPIN1 interaction inhibition rescue experiment |
Nature structural & molecular biology |
High |
40247146
|
| 2020 |
SPIN1 sustains gastric cancer cell proliferation by binding to H3K4me3 at the MDM2 promoter region, activating MDM2 expression. E2F1 directly binds the SPIN1 promoter and activates SPIN1 transcription, forming a SPIN1–MDM2–p21–E2F1 positive feedback loop. |
ChIP (SPIN1 on MDM2 promoter H3K4me3), luciferase reporter (E2F1 on SPIN1 promoter), knockdown/overexpression with cell-cycle and proliferation assays |
Molecular oncology |
Medium |
32767629
|
| 2017 |
Conditional ablation of Spin1 in murine myoblast precursors (Myf5-Cre) causes severe sarcomere disorganization, necrosis, and lethality, with genome-wide Spin1 chromatin occupancy revealing direct target genes including deregulated bHLH transcription factor networks, aberrant titin-associated proteins, and abnormal glycogen metabolism. |
Conditional Spin1 knockout mice (Myf5-Cre), ChIP-seq (primary myoblasts), transcriptome analysis at multiple embryonic stages, histology |
Cell death & disease |
High |
29168801
|
| 2019 |
SPIN.DOC (Spindlin docking protein) directly interacts with SPIN1 via its C-terminal domain; SPIN.DOC overexpression increases SPIN1 expression and chromatin localization. SPIN.DOC knockdown slightly destabilizes SPIN1 without altering its chromatin localization. The SPIN.DOC–SPIN1 complex acts as a transcriptional repressor of Wnt signaling; a C-terminal deletion mutant of SPIN.DOC that cannot bind SPIN1 instead activates Wnt signaling. |
shRNA knockdown, Co-IP (SPIN.DOC–SPIN1), chromatin fractionation, TOPflash Wnt reporter assay, C-terminal deletion mutagenesis |
Biochemical and biophysical research communications |
Medium |
30803761
|
| 2021 |
Spindoc (the Spin1-interacting cofactor that enhances Spin1 binding to histone marks) is dispensable for meiotic division but is specifically required for haploid spermatid development in mice, as shown by CRISPR/Cas9 knockout models. |
CRISPR/Cas9 Spindoc knockout mice (two independent models), histological and spermatid developmental analysis |
Reproductive biology and endocrinology : RB&E |
Medium |
34526015
|
| 2023 |
HNRNPK promotes SPIN1 exon 4 inclusion by interacting with an intronic splicing enhancer in intron 4 of SPIN1 pre-mRNA; exon 4 skipping generates a long non-coding RNA isoform that leads to reduced SPIN1 protein. SPIN1 overexpression partially rescues the growth inhibition caused by HNRNPK knockdown, placing SPIN1 downstream of HNRNPK in an epigenetic cancer regulatory pathway. |
RNA splicing analysis (RT-PCR), HNRNPK knockdown, SPIN1 overexpression rescue, RNABP–RNA interaction mapping (intronic splicing enhancer), cell growth/cell-cycle assays |
Journal of molecular biology |
Medium |
36736887
|
| 2024 |
SLXL1 and SLX (X-linked) compete with SLY1 and SLY2 (Y-linked) for binding to the third Tudor domain of SPIN1 in a dose-dependent, protein-family-specific manner; SLY1 and SLY2 form homo- and heterodimers, indicating competition between multimeric complexes. Positive selection maps to the interaction domains. |
Yeast-based protein–protein interaction assay, domain-deletion mapping (N-terminal and Tudor domain III of SPIN1), competition binding assay, dimerization assay |
bioRxivpreprint |
Medium |
bio_10.1101_2024.10.18.619120
|
| 2016 |
SPIN1 activates the PI3K-Akt signaling pathway in breast cancer cells; knockdown of SPIN1 suppresses PIK3CA, AKT, CREB1, and BCL2, and inhibiting SPIN1 reduces cell migration, invasion, and resistance to chemotherapy. |
miRNA overexpression/inhibition, SPIN1 knockdown/overexpression, Western blot for PI3K-Akt pathway components, in vitro and in vivo (xenograft) functional assays |
The Journal of pathology |
Medium |
27171498
|